tiprankstipranks
Hansa Biopharma AB (MX:HNSAN)
:HNSAN
Mexico Market
HNSAN
Hansa Biopharma AB
RESEARCH TOOLSreports

Hansa Biopharma AB (HNSAN) Ratios

0 Followers

Hansa Biopharma AB Ratios

MX:HNSAN's free cash flow for Q2 2026 was kr0.54. For the 2026 fiscal year, MX:HNSAN's free cash flow was decreased by kr and operating cash flow was kr-4.19. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 1.25 1.94 2.29 2.66 6.06
Quick Ratio
 1.23 1.92 2.28 2.66 6.06
Cash Ratio
 1.00 1.71 1.59 2.28 5.65
Solvency Ratio
 -0.48 -0.40 -0.56 -0.69 -0.55
Operating Cash Flow Ratio
 -0.95 -1.34 -2.64 -2.35 -1.90
Short-Term Operating Cash Flow Coverage
 -1.75 -4.01 0.00 0.00 0.00
Net Current Asset Value
kr -900.10Mkr -454.29Mkr -805.05Mkr -330.77Mkr 520.21M
Leverage Ratios
Debt-to-Assets Ratio
 0.97 0.80 1.35 0.85 0.47
Debt-to-Equity Ratio
 -1.99 -10.49 -1.83 -5.16 1.31
Debt-to-Capital Ratio
 2.01 1.11 2.21 1.24 0.57
Long-Term Debt-to-Capital Ratio
 3.52 1.13 2.24 1.25 0.56
Financial Leverage Ratio
 -2.06 -13.11 -1.36 -6.06 2.80
Debt Service Coverage Ratio
 -1.17 -1.91 -4.81 -6.78 -12.72
Interest Coverage Ratio
 -3.11 -4.43 -4.76 -7.47 -13.19
Debt to Market Cap
 0.26 0.33 0.43 0.61 0.34
Interest Debt Per Share
 12.02 12.95 19.31 18.51 18.58
Net Debt to EBITDA
 -0.85 -0.48 -1.05 -0.19 1.27
Profitability Margins
Gross Profit Margin
57.32%62.41%51.23%52.91%75.10%
EBIT Margin
-306.60%-235.11%-391.17%-540.88%-366.49%
EBITDA Margin
-300.44%-217.68%-374.79%-532.88%-358.69%
Operating Profit Margin
-310.89%-234.27%-372.34%-588.02%-372.83%
Pretax Profit Margin
-405.33%-239.28%-469.43%-619.57%-394.74%
Net Profit Margin
-406.50%-240.30%-471.20%-620.25%-395.49%
Continuous Operations Profit Margin
-406.50%-240.30%-471.20%-620.25%-395.49%
Net Income Per EBT
100.29%100.43%100.38%100.11%100.19%
EBT Per EBIT
130.38%102.14%126.08%105.37%105.88%
Return on Assets (ROA)
-71.92%-45.78%-100.82%-81.70%-36.22%
Return on Equity (ROE)
213.16%600.18%136.86%495.44%-101.36%
Return on Capital Employed (ROCE)
-114.06%-68.87%-117.05%-113.12%-40.50%
Return on Invested Capital (ROIC)
-71.69%-57.78%-115.42%-111.91%-40.29%
Return on Tangible Assets
-93.49%-57.05%-133.80%-94.28%-37.25%
Earnings Yield
-19.03%-19.14%-32.77%-60.42%-27.64%
Efficiency Ratios
Receivables Turnover
 1.46 2.49 1.17 1.72 2.38
Payables Turnover
 1.15 1.26 2.22 0.73 0.62
Inventory Turnover
 10.16 13.63 32.01 41.73 39.54
Fixed Asset Turnover
 23.57 16.65 9.58 4.95 4.31
Asset Turnover
 0.18 0.19 0.21 0.13 0.09
Working Capital Turnover Ratio
 0.53 0.62 0.40 0.14 0.15
Cash Conversion Cycle
 -31.79 -115.95 158.82 -281.58 -429.87
Days of Sales Outstanding
 250.79 146.80 311.77 212.38 153.56
Days of Inventory Outstanding
 35.93 26.79 11.40 8.75 9.23
Days of Payables Outstanding
 318.51 289.54 164.35 502.71 592.66
Operating Cycle
 286.72 173.59 323.17 221.13 162.79
Cash Flow Ratios
Operating Cash Flow Per Share
 -5.19 -6.76 -10.74 -14.38 -11.19
Free Cash Flow Per Share
 -5.37 -6.76 -10.74 -14.39 -11.26
CapEx Per Share
 0.18 0.00 <0.01 <0.01 0.07
Free Cash Flow to Operating Cash Flow
 1.04 1.00 1.00 1.00 1.01
Dividend Paid and CapEx Coverage Ratio
 -28.46 0.00 -5.82K -2.66K -150.93
Capital Expenditure Coverage Ratio
 -28.46 0.00 -5.82K -2.66K -150.93
Operating Cash Flow Coverage Ratio
 -0.51 -0.59 -0.63 -0.87 -0.64
Operating Cash Flow to Sales Ratio
 -2.79 -2.47 -3.94 -5.64 -3.25
Free Cash Flow Yield
-13.78%-19.68%-27.40%-54.92%-22.89%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 -5.06 -5.22 -3.05 -1.66 -3.62
Price-to-Sales (P/S) Ratio
 20.93 12.55 14.38 10.27 14.31
Price-to-Book (P/B) Ratio
 -7.78 -31.35 -4.18 -8.20 3.67
Price-to-Free Cash Flow (P/FCF) Ratio
 -7.26 -5.08 -3.65 -1.82 -4.37
Price-to-Operating Cash Flow Ratio
 -7.67 -5.08 -3.65 -1.82 -4.40
Price-to-Earnings Growth (PEG) Ratio
 1.94 0.11 0.16 -0.10 -0.35
Price-to-Fair Value
 -7.78 -31.35 -4.18 -8.20 3.67
Enterprise Value Multiple
 -7.81 -6.25 -4.89 -2.11 -2.72
Enterprise Value
 4.45B 3.02B 3.14B 1.51B 1.51B
EV to EBITDA
 -7.81 -6.25 -4.89 -2.11 -2.72
EV to Sales
 23.47 13.60 18.31 11.27 9.75
EV to Free Cash Flow
 -8.14 -5.50 -4.65 -2.00 -2.98
EV to Operating Cash Flow
 -8.43 -5.50 -4.65 -2.00 -3.00
Tangible Book Value Per Share
 -7.54 -3.88 -12.53 -5.78 12.38
Shareholders’ Equity Per Share
 -5.11 -1.10 -9.39 -3.20 13.42
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 >-0.01 >-0.01 >-0.01
Revenue Per Share
 1.86 2.74 2.73 2.55 3.44
Net Income Per Share
 -7.57 -6.58 -12.85 -15.83 -13.60
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 1.32 1.02 1.20 1.15 1.08
Research & Development to Revenue
 1.42 1.37 2.19 3.07 2.24
SG&A to Revenue
 2.19 1.60 2.01 3.36 2.19
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.38
Income Quality
 0.77 1.04 0.84 0.91 0.82
Currency in SEK